# A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

> **NCT06916169** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 70 (estimated)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** AG2304
- **DRUG:** AG23041 and AG23042

## Key facts

- **NCT ID:** NCT06916169
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916169, "A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06916169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*